Comparison of national surveillance systems for Lyme disease in humans in Europe and North America: a policy review.

ABSTRACT:

Background

Lyme disease incidence is increasing in Europe, the USA, and Canada. In 2010, a comparison of surveillance systems for Lyme disease (LD) in humans in 28 European countries showed that systems highly varied, making epidemiological comparisons difficult. Details by country were not published. In 2018, one of LD clinical manifestations, neuroborreliosis, was added under European Union (EU) surveillance to standardise definitions. In this study, we identified and compared, 10 years after the European inventory, the characteristics of national surveillance systems and policies for LD in humans, with additional countries.

Methods

Thirty-four European and North American countries were included. Information on national "traditional" systems (which compile data reported by

SUBMITTER: Blanchard L 

PROVIDER: S-EPMC9264653 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature